SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZAULI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.148
AS - Asia 15.153
EU - Europa 9.036
SA - Sud America 2.579
AF - Africa 347
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 56.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.600
SG - Singapore 5.864
CN - Cina 3.680
IT - Italia 2.345
BR - Brasile 2.046
VN - Vietnam 1.762
UA - Ucraina 1.288
DE - Germania 1.284
HK - Hong Kong 1.207
TR - Turchia 898
PL - Polonia 857
GB - Regno Unito 854
FI - Finlandia 550
FR - Francia 458
RU - Federazione Russa 394
JP - Giappone 326
SE - Svezia 326
IN - India 309
CA - Canada 271
ID - Indonesia 224
MX - Messico 209
AR - Argentina 203
NL - Olanda 200
BD - Bangladesh 190
ZA - Sudafrica 147
IQ - Iraq 118
ES - Italia 102
EC - Ecuador 85
PK - Pakistan 81
BE - Belgio 65
CO - Colombia 65
UZ - Uzbekistan 59
SA - Arabia Saudita 57
VE - Venezuela 57
LT - Lituania 50
AT - Austria 43
CZ - Repubblica Ceca 40
CL - Cile 37
PH - Filippine 37
EG - Egitto 34
MY - Malesia 34
AU - Australia 33
MA - Marocco 33
PY - Paraguay 33
JO - Giordania 31
TN - Tunisia 27
AE - Emirati Arabi Uniti 26
KE - Kenya 26
IR - Iran 25
AZ - Azerbaigian 22
IL - Israele 21
KR - Corea 21
UY - Uruguay 21
AL - Albania 20
DZ - Algeria 20
IE - Irlanda 20
NP - Nepal 19
KZ - Kazakistan 16
PE - Perù 16
RO - Romania 16
CH - Svizzera 15
EE - Estonia 15
CR - Costa Rica 14
ET - Etiopia 14
KG - Kirghizistan 14
LK - Sri Lanka 14
DO - Repubblica Dominicana 13
OM - Oman 13
TH - Thailandia 13
TW - Taiwan 13
BO - Bolivia 12
PS - Palestinian Territory 12
PT - Portogallo 12
BG - Bulgaria 11
JM - Giamaica 11
LB - Libano 10
GE - Georgia 9
RS - Serbia 9
HN - Honduras 8
SN - Senegal 8
GR - Grecia 7
NO - Norvegia 7
SK - Slovacchia (Repubblica Slovacca) 7
BH - Bahrain 6
HR - Croazia 6
LV - Lettonia 6
CI - Costa d'Avorio 5
DK - Danimarca 5
KW - Kuwait 5
MD - Moldavia 5
EU - Europa 4
GT - Guatemala 4
LY - Libia 4
NI - Nicaragua 4
PA - Panama 4
TT - Trinidad e Tobago 4
AO - Angola 3
BB - Barbados 3
CY - Cipro 3
HU - Ungheria 3
Totale 56.237
Salva come PNG Salva come JPEG
Città #
Singapore 3.628
Ashburn 3.382
Fairfield 3.039
Woodbridge 2.826
Houston 1.765
San Jose 1.434
Jacksonville 1.386
Ann Arbor 1.271
Chandler 1.231
Seattle 1.204
Hong Kong 1.179
Beijing 1.143
Santa Clara 1.107
Cambridge 1.071
Wilmington 1.062
Warsaw 833
Ho Chi Minh City 580
Ferrara 556
Izmir 491
Los Angeles 468
Dallas 450
Nanjing 391
Hanoi 386
New York 332
Council Bluffs 321
Princeton 312
Tokyo 305
Lauterbourg 285
Boardman 255
Munich 254
Milan 253
San Diego 241
São Paulo 194
Helsinki 185
Shanghai 171
Jakarta 157
Orem 135
Shenyang 128
Mexico City 126
Nanchang 125
Bologna 123
Buffalo 117
Dearborn 110
London 108
Hefei 99
Tianjin 98
Chicago 94
Da Nang 90
Johannesburg 90
Turku 89
Montreal 88
Chennai 86
The Dalles 84
Frankfurt am Main 80
Rome 78
Changsha 77
Denver 75
Hebei 70
Haiphong 69
Brooklyn 67
Moscow 67
Stockholm 65
Jiaxing 64
Brussels 62
Dong Ket 62
Columbus 61
Falls Church 61
Toronto 61
Mountain View 60
Atlanta 56
Poplar 56
Bremen 55
Jinan 55
San Francisco 53
San Mateo 51
Rio de Janeiro 50
Boston 48
Norwalk 48
Zhengzhou 48
Tashkent 47
Baghdad 46
Kunming 46
Manchester 46
Mumbai 45
Phoenix 43
Auburn Hills 42
Falkenstein 42
Belo Horizonte 40
Curitiba 40
Redwood City 38
Ankara 37
Hải Dương 36
Porto Alegre 35
Amsterdam 34
Guangzhou 33
Nuremberg 33
Tappahannock 33
Quito 32
Orange 31
Verona 29
Totale 38.345
Salva come PNG Salva come JPEG
Nome #
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence 421
Trattato di Anatomia Umana 352
Trattato di Anatomia Umana 326
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 324
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 297
Targeting mTOR in Acute Lymphoblastic Leukemia 292
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 285
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 283
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 272
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 271
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 271
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 271
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 270
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 264
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 264
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 264
Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation 261
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 253
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 253
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 250
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 250
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity 249
Antiangiogenic activity of the MDM2 antagonist nutlin-3 248
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 247
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 247
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 246
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 246
Association between thyroid hormones and TRAIL 245
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 244
The synthetic cathinones MDPHP and MDPV: Comparison of the acute effects in mice, in silico ADMET profiles and clinical reports 241
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 238
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 237
Actively targeted nanocarriers for drug delivery to cancer cells 237
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 236
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 236
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 235
A Brain Hidden in the Ferrara Cathedral: A Novel Interpretation of a Renaissance Masterpiece 235
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 232
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 232
All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. 231
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 228
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 228
Cytokine levels in the serum of healthy subjects 227
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 226
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 226
The circulating levels of TRAIL are extremely low after delivery but rapidly recover in both mothers and newborns 224
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 224
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 223
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 223
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 223
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 222
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 221
Clinical perspectives of TRAIL: Insights into central nervous system disorders 220
Flow cytometric quantification of HIV-1 Tat protein in tat-transfected Jurkat T cell lines 215
Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol 215
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 214
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 214
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 213
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 212
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 211
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 209
Extracellular HIV-1 tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid jurkat cells 208
Human Herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4+ T Cells 208
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 208
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity 207
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 207
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 207
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 206
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 206
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 204
Stroma-derived factor 1α induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand 203
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 203
Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells 202
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 202
Accuracy of intraocular lens power calculation for cataract surgery after deep anterior lamellar keratoplasty 202
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 201
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 200
HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway 200
In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions 200
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 200
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 199
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 198
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 198
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 197
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 197
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 197
HIV-1 Tat induces tyrosine phosphorylation of p125(FAK) and its association with phosphoinositide 3-kinase in PC12 cells 196
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 194
Exogenous human immunodeficiency virus type‐1 Tat protein selectively stimulates a phosphatidylinositol‐specific phospholipase C nuclear pathway in the Jurkat T cell line 193
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities 193
Molecular targets for selective killing of TRAIL-resistant leukemic cells. 191
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 190
Role of physical exercise in the regulation of epigenetic mechanisms in inflammation, cancer, neurodegenerative diseases, and aging process 190
The CD4 receptor plays essential but distinct roles in HIV‐1 infection and induction of apoptosis in primary bone marrow GPIIb/IIIa+ megakaryocytes and the HEL cell line 190
Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells 188
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 188
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 187
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 186
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 185
Endothelial PDGF-BB produced ex vivo correlates with relevant hemodynamic parameters in patients affected by chronic venous disease 184
Totale 22.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.929
Totale 237.161
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.560 0 0 0 0 0 0 0 0 0 718 526 316
2021/20223.048 109 312 243 136 158 180 158 177 119 257 363 836
2022/20233.019 334 136 119 357 462 472 103 271 387 52 186 140
2023/20241.541 179 207 73 42 106 195 61 147 42 41 64 384
2024/20257.965 257 192 604 332 995 610 356 485 1.372 775 1.125 862
2025/202620.284 2.133 961 1.984 2.733 3.033 1.508 2.515 1.271 2.081 2.065 0 0
Totale 56.979